Purple Biotech Q3 EPS $(0.60) Beats $(2.88) Estimate

Benzinga · 17h ago
Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(2.88) by 79.17 percent. This is a 79.02 percent increase over losses of $(2.86) per share from the same period last year.